Rare Diseases Drive Personalized Medicine Growth: A Key Driver Powering Personalized Medicine Market Growth In 2025

The Personalized Medicine Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].

How Big Is the Personalized Medicine Market Size Expected to Be by 2034?
In recent times, the personalized medicine market has seen accelerated growth. The market size is set to expand from $386.27 billion in 2024 to $426.82 billion in 2025, with a Compound Annual Growth Rate (CAGR) of 10.5%. Factors such as companion diagnostics' rise, a more patient-focused approach to healthcare, a shift in drug development, concentration on controlling healthcare costs, and growing chronic disease prevalence have contributed to this historic period of growth.

In the coming years, a substantial expansion is expected in the personalized medicine market size, which is projected to reach $662.67 billion in 2029 with a compound annual growth rate (CAGR) of 11.6%. This growth during the forecast period may be a result of ongoing developments in genomics, the broadening of biomarker discovery, increased acceptance of telemedicine, regulatory backing and structure, as well as cooperation and data exchange. The forecast period is also likely to witness significant trends including the utilization of artificial intelligence (AI), advancements in genomic sequencing, data integration and analytics, immunotherapy and specialized therapies, patient empowerment and informed decision-making, collaborations and partnerships.

Purchase the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=10272

What Are the Emerging Segments Within the Personalized Medicine Market?
The personalized medicine market covered in this report is segmented -

1) By Product: Personalized Medicine Diagnostics, Personalized Medicine Therapeutics, Personalized Medical Care, Personalized Nutrition and Wellness
2) By Application: Oncology, Neurology, Blood Transfusion Safety, Diabetes, Autoimmune Diseases, Cardiology, Other Applications
3) By End-use: Hospitals, Diagnostic Centers, Research and Academic Institutes, Other End-Users

Subsegments:
1) By Personalized Medicine Diagnostics: Genetic Testing, Biomarker Testing, Companion Diagnostics, Molecular Imaging
2) By Personalized Medicine Therapeutics: Targeted Therapies, Gene Therapies, Monoclonal Antibodies, Cell and Gene Therapy Products
3) By Personalized Medical Care: Tailored Treatment Plans, Patient-Centric Care Models, Digital Health Solutions, Remote Patient Monitoring
4) By Personalized Nutrition And Wellness: Nutrigenomics, Customized Diet Plans, Supplement Personalization, Lifestyle Modification Programs

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=10272&type=smp

What Long-Term Drivers Are Shaping Personalized Medicine Market Trends?
The growth of the personalized medicine market is projected to be driven by the increasing occurrence of rare diseases. This surge pertains to an escalating number of individuals being diagnosed with disorders like Klinefelter Syndrome, Aarskog Syndrome, and Abetalipoproteinemia. Tailored treatment options designed to meet the unique needs of patients suffering from such rare diseases are offered by personalized medicine. For instance, the Genetic Alliance UK, a national charity based in the UK that supports people affected by rare, genetic, and undiagnosed conditions, reported in February 2024, that there are 3.5 million people in the UK living with a rare condition, and that 1 in 17 individuals will suffer from a rare disease at some point in their lives. So, as the incidence of rare diseases continues to increase, it contributes to the swelling size of the personalized medicine market.

Who Are the Top Competitors in Key Personalized Medicine Market Segments?
Major companies operating in the personalized medicine market include Bayer AG, Novartis AG, Thermo Fisher Scientific Inc., GlaxoSmithKline plc, AstraZeneca plc, Abbott Laboratories, Danaher Corporation, Eli Lilly and Company, Decode Genetics Inc., GE HealthCare Technologies Inc., Roche Diagnostics, Genentech Inc., Biogen Inc., Illumina Inc., Qiagen N.V., Exact Sciences Corporation, Myriad Genetics Inc., Verily Life Sciences LLC, Guardant Health Inc., Tempus Labs, Oxford Nanopore Technologies, Foundation Medicine Inc., NanoString Technologies Inc., Exagen Inc., Asuragen Inc., Personal Genome Diagnostics, Precision Biologics Inc., Strata Oncology, Genelex Corp, Invitae Corporation, Color Genomics, Helix OpCo LLC, 10x Genomics Inc., Agena Bioscience Inc., Natera Inc., Becton Dickinson and Company, PerkinElmer Inc., Sophia Genetics, Genomic Vision, Personalis Inc.

What Are the Major Trends Shaping the Personalized Medicine Market?
The emergence of technological innovations is a notable trend prevalent in the personalized medicine market. Numerous key players in the personalized medicine industry are harnessing these new technologies to maintain their market dominance. For instance, in April 2023, US-based healthcare firm OM1, renowned for utilizing real-world data and artificial intelligence (AI) to support healthcare providers, patented an AI-driven platform designed to expedite the provision of personalized medicine. This technology takes advantage of comprehensive data analysis to deliver insightful revelations about diagnoses, disease progression, and responses to treatments. Crucially, this technology enables the provision of customized healthcare solutions, aids healthcare providers in making informed decisions, and hastens clinical trials through efficient patient selection - all of which contribute substantially to the evolution of the personalized medicine market.

Get the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/report/personalized-medicine-global-market-report

Which Regions Are Becoming Hubs for Personalized Medicine Market Innovation?
North America was the largest region in the personalized medicine market in 2024. Asia-pacific is expected to be the fastest-growing region in the global personalized medicine market during the forecast period. The regions covered in the personalized medicine market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Frequently Asked Questions:
1. What Is the Market Size and Growth Rate of the Personalized Medicine Market?
2. What is the CAGR expected in the Personalized Medicine Market?
3. What Are the Key Innovations Transforming the Personalized Medicine Industry?
4. Which Region Is Leading the Personalized Medicine Market?

Why This Report Matters:

Competitive overview: This report analyzes the competitive landscape of the 3D imaging software market, evaluating key players on market share, revenue, and growth factors.

Informed Decisions: Understand key strategies related to products, segmentation, and industry trends.

Efficient Research: Quickly identify market growth, leading players, and major segments.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.